ETF MANAGERS GROUP, LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 45 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ETF MANAGERS GROUP, LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$310,955
-61.2%
723,151
-52.1%
0.01%
-73.7%
Q4 2022$800,762
-51.6%
1,510,872
-33.1%
0.04%
-28.3%
Q3 2022$1,654,000
-41.2%
2,258,970
-7.7%
0.05%
-34.6%
Q2 2022$2,815,000
-64.2%
2,447,407
-33.2%
0.08%
-48.7%
Q1 2022$7,874,000
-41.0%
3,662,342
-20.1%
0.16%
-40.2%
Q4 2021$13,345,000
-28.8%
4,585,741
+2.7%
0.26%
-25.2%
Q3 2021$18,748,000
-24.5%
4,463,774
-2.5%
0.35%
-12.8%
Q2 2021$24,820,000
+168.5%
4,579,280
+130.4%
0.40%
+147.0%
Q1 2021$9,243,000
+54.4%
1,987,786
+9.6%
0.16%
+25.2%
Q4 2020$5,987,000
+103.0%
1,814,328
+103.6%
0.13%
+39.4%
Q3 2020$2,949,000
-29.5%
891,025
-28.2%
0.09%
-36.5%
Q2 2020$4,184,000
-9.6%
1,241,596
+2.8%
0.15%
-31.2%
Q1 2020$4,627,000
-62.4%
1,208,126
-40.7%
0.22%
-49.8%
Q4 2019$12,301,000
-39.3%
2,036,530
-24.0%
0.43%
-41.3%
Q3 2019$20,257,000
-33.2%
2,679,457
+19.7%
0.73%
-24.5%
Q2 2019$30,323,0002,237,8430.96%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Beryl Capital Management LLC 4,898,927$6,246,1320.70%
Yakira Capital Management, Inc. 620,019$790,5240.22%
Crystalline Management Inc. 230,817$294,2920.21%
DELTEC ASSET MANAGEMENT LLC 475,000$605,6250.14%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,283,979$2,912,0730.12%
PenderFund Capital Management Ltd. 123,444$2130.06%
FIFTH LANE CAPITAL, LP 100,000$127,0000.04%
CSS LLC/IL 476,831$607,9600.04%
Penserra Capital Management LLC 220,858$2800.01%
King Wealth Management Group 16,000$200.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders